Cargando…

Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy

The endocannabinoid system refers to a widespread signaling system and its alteration is implicated in a growing number of human diseases. However, the potential role of endocannabinoids in skeletal muscle disorders remains unknown. Here we report the role of the endocannabinoid CB1 receptors in Duc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iannotti, Fabio A., Pagano, Ester, Guardiola, Ombretta, Adinolfi, Simone, Saccone, Valentina, Consalvi, Silvia, Piscitelli, Fabiana, Gazzerro, Elisabetta, Busetto, Giuseppe, Carrella, Diego, Capasso, Raffaele, Puri, Pier Lorenzo, Minchiotti, Gabriella, Di Marzo, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160489/ https://www.ncbi.nlm.nih.gov/pubmed/30262909 http://dx.doi.org/10.1038/s41467-018-06267-1

Ejemplares similares

Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin
por: Kalkan, Hilal, et al.
Publicado: (2023)

Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy
por: Kalkan, Hilal, et al.
Publicado: (2023)

Muscle-specific microRNAs as biomarkers of Duchenne Muscular Dystrophy progression and response to therapies
por: Giordani, L, et al.
Publicado: (2014)

CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy
por: Argenziano, Maura, et al.
Publicado: (2023)

Alterations of the endocannabinoid system and circulating and peripheral tissue levels of endocannabinoids in sarcopenic rats
por: Le Bacquer, Olivier, et al.
Publicado: (2021)

Orexin-A and endocannabinoids are involved in obesity-associated alteration of hippocampal neurogenesis, plasticity, and episodic memory in mice
por: Forte, Nicola, et al.
Publicado: (2021)

Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia
por: Stark, Tibor, et al.
Publicado: (2022)

Peripheral Endocannabinoid Responses to Hedonic Eating in Binge-Eating Disorder
por: Monteleone, Alessio Maria, et al.
Publicado: (2017)

Role of 2-Arachidonoyl-Glycerol and CB1 Receptors in Orexin-A-Mediated Prevention of Oxygen–Glucose Deprivation-Induced Neuronal Injury
por: Palomba, Letizia, et al.
Publicado: (2020)

Structural basis for activation of CB1 by an endocannabinoid analog
por: Krishna Kumar, Kaavya, et al.
Publicado: (2023)

The Endocannabinoid System: A Target for Cancer Treatment
por: Laezza, Chiara, et al.
Publicado: (2020)

Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study
por: Valastro, Carmela, et al.
Publicado: (2017)

Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity
por: Panza, E., et al.
Publicado: (2021)

Endocannabinoid engagement of CB(2) regulates RSV-induced immunity
por: Kaplan, Barbara L. F.
Publicado: (2018)

The Endocannabinoid System: A Bridge between Alzheimer’s Disease and Gut Microbiota
por: Bisogno, Tiziana, et al.
Publicado: (2021)

Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis
por: Ferrara, Anne Lise, et al.
Publicado: (2019)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Pharmacological characterization of the endocannabinoid sensor GRAB(eCB2.0)
por: Singh, Simar, et al.
Publicado: (2023)

Overlapping Distribution of Orexin and Endocannabinoid Receptors and Their Functional Interaction in the Brain of Adult Zebrafish
por: Imperatore, Roberta, et al.
Publicado: (2018)

Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome
por: Rubio, Marta, et al.
Publicado: (2016)

Endocannabinoid-dependent disinhibition of orexinergic neurons: Electrophysiological evidence in leptin-knockout obese mice
por: Becker, Thorsten Michael, et al.
Publicado: (2017)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019)

Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Eteplirsen in the treatment of Duchenne muscular dystrophy
por: Lim, Kenji Rowel Q, et al.
Publicado: (2017)

Nutritional Challenges in Duchenne Muscular Dystrophy
por: Salera, Simona, et al.
Publicado: (2017)

Lifetime Care of Duchenne Muscular Dystrophy
por: MacKintosh, Erin W., et al.
Publicado: (2020)

The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Gene Therapy for Duchenne Muscular Dystrophy
por: Elangkovan, Nertiyan, et al.
Publicado: (2021)

Family reflections: Duchenne Muscular Dystrophy
por: Gill, Omaira
Publicado: (2022)

Cardiac therapies for Duchenne muscular dystrophy
por: Shah, Md Nur Ahad, et al.
Publicado: (2023)

Endocannabinoid signalling in the blood of patients with schizophrenia
por: De Marchi, Nicola, et al.
Publicado: (2003)

Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
por: Barp, Andrea, et al.
Publicado: (2015)

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r0q0u2jdm2jdo9t5qk9jfdn3nd